Next Article in Journal
Influence of Lenvatinib on the Functional Reprogramming of Peripheral Myeloid Cells in the Context of Non-Medullary Thyroid Carcinoma
Next Article in Special Issue
Nanobiotechnology-Enabled mRNA Stabilization
Previous Article in Journal
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study
Previous Article in Special Issue
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(2), 410; https://doi.org/10.3390/pharmaceutics15020410
Action Date Notes Link
article pdf uploaded. 26 January 2023 08:40 CET Version of Record https://www.mdpi.com/1999-4923/15/2/410/pdf-vor
article supplementary file uploaded. 26 January 2023 08:40 CET - https://www.mdpi.com/1999-4923/15/2/410#supplementary
article xml file uploaded 14 February 2023 06:26 CET Original file -
article xml uploaded. 14 February 2023 06:26 CET Update https://www.mdpi.com/1999-4923/15/2/410/xml
article pdf uploaded. 14 February 2023 06:26 CET Updated version of record https://www.mdpi.com/1999-4923/15/2/410/pdf
article html file updated 14 February 2023 06:28 CET Original file -
article html file updated 8 March 2023 02:21 CET Update https://www.mdpi.com/1999-4923/15/2/410/html
Back to TopTop